4890.T Tsubota Laboratory (JPX) up 13.86% pre-market 12 Mar 2026: volume surge

4890.T stock opened the pre-market session sharply higher on 12 Mar 2026, trading at JPY 345.00 after a 13.86% jump and a volume spike to 4,013,500.00 shares. The move follows heavy intraday activity versus an average volume of 87,900.00 shares. We track price action on the JPX and connect it to news flow, sector tone and short-term signals to assess if this rally can extend into the regular session.

Pre-market move and intraday data for 4890.T stock

Tsubota Laboratory (4890.T) traded between JPY 305.00 and JPY 383.00 in early action, with the last quoted price at JPY 345.00. One clear fact: volume reached 4,013,500.00, or 45.66x the stock’s average, which signals heavy attention ahead of the open.

The stock’s one-day change was JPY 42.00 or 13.86%, while the 50-day average sits at JPY 307.82 and the 200-day average at JPY 350.91. These averages show a mixed trend into today.

What drove the jump: news, volume and Healthcare sector context for 4890.T stock

There is no single regulatory release tied to the spike. The trade looks driven by speculative flows, volume-driven momentum, and sector strength. The Healthcare sector in Japan has delivered 3M performance of 2.73%, offering mild support to smaller pharma names.

We note investor focus on Tsubota Laboratory’s pipeline for myopia and dry-eye treatments. That narrative often amplifies moves when liquidity surges. For broader market context see news source.

Fundamentals and valuation for Tsubota Laboratory (4890.T)

Tsubota Laboratory reports EPS of -6.79 and a trailing PE of -50.81, reflecting negative earnings. The company shows strong cash per share at JPY 45.84 and book value per share at JPY 42.86, producing a price-to-book near 7.07 at the current price.

Revenue per share is JPY 27.55, and the current ratio is 3.17, which supports liquidity. Investors should weigh high valuation multiples against research intensity and R&D spending near 35.75% of revenue.

Technical snapshot and trading signals for 4890.T stock

Momentum indicators show a short-term bullish tilt. RSI reads 57.54, MACD histogram is positive, and ADX at 29.88 signals a strong trend. Bollinger middle band sits at JPY 275.00, with the upper band at JPY 299.37.

Short-term risk includes an overbought CCI at 157.22 and very wide intraday ranges. Traders should monitor the open interest in the regular session and use tight risk controls given the stock’s jump and thin free float.

Meyka AI rates 4890.T with a score out of 100 and forecast

Meyka AI rates 4890.T with a score out of 100: the model assigns 69.78 / 100, grade B, suggestion HOLD. This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a quarterly price of JPY 279.06, implying a -19.13% downside versus the current JPY 345.00. Forecasts are model-based projections and not guarantees. Meyka AI, an AI-powered market analysis platform, flags valuation risk amid short-term momentum.

Risks, scenarios and price targets for 4890.T stock

Key risks include continued negative EPS, volatile trading volume, and a high price-to-book ratio near 7.07. Operational risks tie to clinical results and regulatory timelines for ophthalmology products.

Analyst scenario: bull target JPY 460.00 (year high), base target JPY 380.00, bear target JPY 260.00. These levels align with recent highs and the firm’s liquidity profile. Position sizing should reflect the stock’s volatility and narrow institutional float.

Final Thoughts

4890.T stock posted a notable pre-market gain on 12 Mar 2026, led by a 13.86% price jump to JPY 345.00 and a massive volume surge to 4,013,500.00 shares. Short-term technicals favour momentum, but fundamentals show negative EPS (-6.79) and a high price-to-book of 7.07. Meyka AI rates 4890.T at 69.78 / 100 with a grade B and a HOLD suggestion, reflecting mixed signals from growth and valuation. Meyka AI’s forecast model projects a quarterly price of JPY 279.06, implying -19.13% downside versus the current price. Traders should treat today’s move as a liquidity-driven event and watch for follow-through or reversal in the regular session. Use tight stops and consider scenario-based targets: bull JPY 460.00, base JPY 380.00, bear JPY 260.00. Forecasts are model projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.